SHOCKWAVE MEDICAL INC (SWAV) Stock Analyst Earnings Estimates
NASDAQ:SWAV - Nasdaq - US82489T1043 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 237.1M 249.71% | 489.7M 106.54% | 730.23M 49.12% | 946.59M 29.63% | 1.155B 22.02% | 1.4B 21.21% | 1.652B 18.00% | 1.852B 12.11% | 2.186B 18.03% | 2.501B 14.41% | |
| EBITDA YoY % growth | 2.7M 104.23% | 129M 4,677.78% | 169.451M 31.36% | 265.92M 56.93% | 311.48M 17.13% | 459.79M 47.61% | 596.44M 29.72% | N/A | N/A | N/A | |
| EBIT YoY % growth | -900K 98.63% | 124.1M 13,888.89% | 159.093M 28.20% | 220.45M 38.57% | 299.89M 36.04% | 391.68M 30.61% | 499.51M 27.53% | 560.86M 12.28% | N/A | N/A | |
| Operating Margin | -0.38% | 25.34% | 21.79% | 23.29% | 25.96% | 27.98% | 30.24% | 30.28% | N/A | N/A | |
| EPS YoY % growth | -0.30 84.92% | 3.17 1,156.67% | 3.87 22.08% | 5.27 36.11% | 6.31 19.71% | 7.41 17.44% | 8.86 19.63% | 8.69 -1.90% | N/A | N/A |
All data in USD
| Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.19 56.76% | 1.25 35.70% | 1.51 30.14% | 1.42 -1.36% | 1.57 31.68% | 1.62 30.07% | 1.82 20.33% | 1.63 14.79% | 1.82 15.99% | 1.90 16.80% | 2.11 16.40% |
| Revenue Q2Q % growth | 232M 28.77% | 236.59M 27.19% | 259M 27.60% | 260.5M 19.06% | 284.43M 22.60% | 290.48M 22.78% | 320.82M 23.87% | 295.9M 13.59% | 322.73M 13.47% | 328.95M 13.24% | 367.2M 14.46% |
| EBITDA Q2Q % growth | 69.384M 89.06% | 75.432M 48.20% | 80.549M 50.17% | 78.035M 71.45% | 86.404M 24.53% | 91.764M 21.65% | 102.14M 26.80% | 99.96M 28.10% | 109.14M 26.31% | 110.16M 20.05% | 125.46M 22.83% |
| EBIT Q2Q % growth | 51.568M 59.16% | 54.539M 25.09% | 66.035M 52.57% | 58.877M 38.84% | 69.039M 33.88% | 72.392M 32.73% | 86.012M 30.25% | 79.152M 34.44% | 86.292M 24.99% | 88.026M 21.60% | 98.226M 14.20% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | 1.44 39.81% | 1.00 | 0.44 | 44.66% |
| Q4 2023 Q2Q % growth | 1.16 -1.69% | 0.91 | 0.25 | 27.98% |
| Q3 2023 Q2Q % growth | 0.92 | 0.81 | 0.11 | 13.65% |
| Q2 2023 Q2Q % growth | 0.76 11.76% | 0.87 | -0.11 | -12.88% |
| Q1 2023 Q2Q % growth | 1.03 164.10% | 0.83 | 0.20 | 24.84% |
| Q4 2022 Q2Q % growth | 1.18 247.06% | 1.03 | 0.15 | 15.08% |
| Q3 2022 Q2Q % growth | 0.92 1,740.00% | 0.68 | 0.24 | 34.91% |
| Q2 2022 Q2Q % growth | 0.68 6,900.00% | 0.45 | 0.23 | 51.52% |
| Q1 2022 Q2Q % growth | 0.39 157.35% | 0.19 | 0.20 | 107.47% |
| Q4 2021 Q2Q % growth | 0.34 173.91% | 0.09 | 0.25 | 292.16% |
| Q3 2021 Q2Q % growth | 0.05 113.16% | -0.06 | 0.11 | 185.79% |
| Q2 2021 Q2Q % growth | -0.01 98.21% | -0.41 | 0.40 | 97.54% |
| Q1 2021 Q2Q % growth | -0.68 -15.25% | -0.46 | -0.22 | -49.25% |
| Q4 2020 Q2Q % growth | -0.46 6.12% | -0.43 | -0.03 | -6.53% |
| Q3 2020 Q2Q % growth | -0.38 17.39% | -0.56 | 0.18 | 32.67% |
| Q2 2020 Q2Q % growth | -0.56 -47.37% | -0.63 | 0.07 | 11.69% |
| Q1 2020 Q2Q % growth | -0.59 56.93% | -0.50 | -0.09 | -17.65% |
| Q4 2019 Q2Q % growth | -0.49 | -0.52 | 0.03 | 5.43% |
| Q3 2019 Q2Q % growth | -0.46 | -0.52 | 0.06 | 11.57% |
| Q2 2019 Q2Q % growth | -0.38 | -0.54 | 0.16 | 29.37% |
| Q1 2019 Q2Q % growth | -1.37 | -0.53 | -0.84 | -159.54% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | 218.805M 35.85% | 211.84M | 6.965M | 3.29% |
| Q4 2023 Q2Q % growth | 202.979M 40.96% | 203.44M | -461K | -0.23% |
| Q3 2023 Q2Q % growth | 186.02M 41.68% | 188.42M | -2.4M | -1.27% |
| Q2 2023 Q2Q % growth | 180.165M 49.27% | 177.25M | 2.915M | 1.64% |
| Q1 2023 Q2Q % growth | 161.066M 72.08% | 150.26M | 10.806M | 7.19% |
| Q4 2022 Q2Q % growth | 144M 71.02% | 145.45M | -1.45M | -1.00% |
| Q3 2022 Q2Q % growth | 131.3M 101.38% | 126.45M | 4.85M | 3.84% |
| Q2 2022 Q2Q % growth | 120.7M 115.92% | 109.67M | 11.03M | 10.06% |
| Q1 2022 Q2Q % growth | 93.6M 193.42% | 88.135M | 5.465M | 6.20% |
| Q4 2021 Q2Q % growth | 84.2M 270.93% | 76.943M | 7.257M | 9.43% |
| Q3 2021 Q2Q % growth | 65.2M 232.65% | 62.421M | 2.779M | 4.45% |
| Q2 2021 Q2Q % growth | 55.9M 442.72% | 46.111M | 9.789M | 21.23% |
| Q1 2021 Q2Q % growth | 31.9M 109.87% | 30.498M | 1.402M | 4.60% |
| Q4 2020 Q2Q % growth | 22.7M 58.74% | 20.555M | 2.145M | 10.44% |
| Q3 2020 Q2Q % growth | 19.6M 73.45% | 14.98M | 4.62M | 30.84% |
| Q2 2020 Q2Q % growth | 10.3M 3.00% | 8.517M | 1.783M | 20.93% |
| Q1 2020 Q2Q % growth | 15.2M 108.22% | 14.457M | 743K | 5.14% |
| Q4 2019 Q2Q % growth | 14.3M | 13.754M | 546K | 3.97% |
| Q3 2019 Q2Q % growth | 11.3M | 10.625M | 675K | 6.35% |
| Q2 2019 Q2Q % growth | 10M | 8.452M | 1.548M | 18.32% |
| Q1 2019 Q2Q % growth | 7.3M | 5.807M | 1.493M | 25.71% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.66% | -2.74% | 6.44% | 16.18% |
| Revenue | 0.35% | 0.36% | 0.78% | 0.99% |